ELMS STEVE Insider Trading Activity

Average Profitability
<0.0001%
Insider Buys Quantity
3
Insider Buys Sum
$5.42M
Insider Sells Quantity
5
Insider Sells Sum
$9.14M

Insider Activity of ELMS STEVE

According to the SEC Form 4 filings, ELMS STEVE, being in a position of

  1. director at ADMA Biologics, Inc.,
    оver the last 12 months, has bought 14000 shares for $217,420, and sold 0 shares,
    over all time since 2024-03-13, has bought 14000 shares for $217,420, and sold 1925621 share for $17.97M.

Biography of ELMS STEVE

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
 $217,4202100
Sells
 $000

Comparison of Insiders on Amount of Buys and Sells

2026-03-06PurchaseADMA Biologics, Inc.
ADMA
director
7,000
0.0029%
$15.39$107,730-38.6%
2026-03-05PurchaseADMA Biologics, Inc.
ADMA
director
7,000
0.0029%
$15.67$109,690-39.75%
2025-06-16SaleADMA Biologics, Inc.
ADMA
director
194,749
0.0809%
$20.24$3.94M-21.42%
2025-06-13SaleADMA Biologics, Inc.
ADMA
director
137,931
0.0578%
$20.82$2.87M-22.66%
2025-06-12SaleADMA Biologics, Inc.
ADMA
director
92,941
0.0391%
$21.69$2.02M-25.46%
2024-12-23PurchaseMarker Therapeutics, Inc.
MRKR
director
11,085
0.1154%
$3.20$35,472-63.3%
2024-03-19SaleADMA Biologics, Inc.
ADMA
director
411,829
0.1772%
$6.08$2.5M+161.39%
2024-03-18SaleADMA Biologics, Inc.
ADMA
director
49,887
0.0221%
$6.01$299,821+172.22%
2024-03-15SaleADMA Biologics, Inc.
ADMA
director
183,008
0.0805%
$6.01$1.1M+169.78%
2024-03-14SaleADMA Biologics, Inc.
ADMA
director
448,276
0.1906%
$6.05$2.71M+168.36%
2024-03-13SaleADMA Biologics, Inc.
ADMA
director
407,000
0.1776%
$6.21$2.53M+157.75%
2021-03-16PurchaseMarker Therapeutics, Inc.
MRKR
director
1.14M
1.9041%
$1.75$2M-4.3%
Total: 12
Company
About Prismo.proIdeasArticlesPrivacy PolicyTerms of ServiceContact Us
Screener Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksStock NewsInsider RatioList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.